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Abstract
Background: Species of the genus Aeromonas are native inhabitants of aquatic environments and have recently been
considered emerging human pathogens. Although the gastrointestinal tract is by far the most common anatomic site from
which aeromonads are recovered, their role as etiologic agents of bacterial diarrhea is still disputed. Aeromonas-associated
diarrhea is a phenomenon occurring worldwide; however, the exact prevalence of Aeromonas infections on a global scale is
unknown.
Methodology/Principal Findings: The prevalence and virulence potential of Aeromonas in patients suffering from diarrhea
in Israel was studied using molecular methods. 1,033 diarrheal stools were sampled between April and September 2010 and
Aeromonas species were identified in 17 (,2%) patients by sequencing the rpoD gene. Aeromonas species identity and
abundance was: A. caviae (65%), A. veronii (29%) and Aeromonas taiwanensis (6%). This is the first clinical record of A.
taiwanensis as a diarrheal causative since its recent discovery from a wound infection in a patient in Taiwan. Most of the
patients (77%) from which Aeromonas species were isolated were negative for any other pathogens. The patients ranged
from 1 to 92 years in age. Aeromonas isolates were found to possess different virulence-associated genes: ahpB (88%), pla/
lip/lipH3/apl-1 (71%), act/hlyA/aerA (35%), alt (18%), ast (6%), fla (65%), lafA (41%), TTSS ascV (12%), TTSS ascF-ascG (12%),
TTSS-dependent ADP-ribosylating toxins aexU (41%) and aexT (6%) in various combinations. Most of the identified strains
were resistant to beta-lactam antibiotics but susceptible to third-generation cephalosporin antibiotics.
Conclusions: Aeromonas may be a causative agent of diarrhea in patients in Israel and therefore should be included in
routine bacteriological screenings.
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Introduction
Aeromonas species are waterborne, Gram-negative, oxidase-
positive, rod-shaped bacteria that are ubiquitous in water. This
includes chlorinated drinking water, as the bacteria can grow and
survive in biofilms in the water distribution systems [1]. The
prevalence of Aeromonas species in the aquatic environment has
been recognized as a potential health risk, and some countries
have adopted aeromonad counts as an additional indicator of
water quality [2].
The most common clinical manifestations of Aeromonas infections
are diarrhea, bacteremia and localized soft-tissue infections [3].
Patients may acquire Aeromonas infections both in community and
hospital settings [3–5]. Both immunocompetent and immuno-
compromised patients are susceptible to Aeromonas infections [3,6].
The gastrointestinal tract is by far the most common anatomic site
from which aeromonads are recovered [3,6]. Aeromonas have been
isolated from children with acute diarrhea and from adults with
traveler’s diarrhea [3,6–8]. The following species are frequently
associated with diarrhea in humans: A. hydrophila, A. veronii bv.
sobria and A. cavia [3,6,9,10,11].
The mechanism of Aeromonas pathogenesis is complex and not
well understood. Aeromonas virulence is considered to be multifac-
torial. The virulence factors that were associated with Aeromonas
pathogenicity are: cytotoxic enterotoxin, haemolysins, proteases
[serine protease (aspA), elastase (ahpB)], lipases (pla and plc, sat),
DNAses and adhesins [type IV pili and polar flagella (flaA and
flaB)] [1,6,9,10,12,13]. Several of these virulence factors have been
identified in strains isolated from water [1]. In addition, genes for a
type III secretion system (TTSS) were identified in this genus
[14,15]. TTSS has a role in delivering toxins directly into the host
cell and in inducing apoptosis [14,15].
In Israel, diarrhea patients are tested routinely by clinical
laboratories for the presence of several bacterial pathogens, such
as: Campylobacter spp., Shigella spp. and Salmonella spp., but not for
Aeromonas. The aim of this research was to study the prevalence
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Aeromonas Prevalence in Diarrheal Stools
The presence of Aeromonas was monitored in fecal specimens
from diarrheal patients submitted to the Microbiology Laboratory
of Clalit Health Services in Haifa. This Laboratory provides
services to a wide range of population, from the district of Haifa
and West Galilee in Israel (this is a community health service, not
a hospital). The surveillance was conducted between April 13 and
September 15, 2010 (five months). All specimens were checked
routinely for the following enteropathogens: Shigella, Salmonella and
Campylobacter spp. were isolated and identified by conventional
methods [16]; Rotavirus was detected by an antigen detection
method (Novamed, Israel); parasites were studied according to
methods described in Garcia and Isenberg [17]. For the isolation
of Aeromonas spp. the fecal specimens were either enriched in
alkaline peptone water (APW) containing peptone (1%, wt/vol)
and NaCl (1%, wt/vol) pH 8.5, or directly streaked on a selective
m-Aeromonas agar base (Havelaar Biolife, Milano, Italy). In the
case of enrichment, the tubes were incubated at 37uC without
shaking for 6–18 h, and then streaked on m-Aeromonas selective
agar. The agar plates were incubated overnight at 37uC. Colonies
that were morphologically suspected as Aeromonas (yellow, smooth
and rounded) were subcultured onto LB agar (Himedia, India),
and then tested for oxidase (1% tetramethyl-phenylenediamine,
Sigma). The identity of the isolates with positive results was further
verified by Aeromonas genus specific PCR assay in accordance with
Kong et al. (1999) [18]. Reddy Mix PCR master mixture (ABgene,
Epsom, UK) was used for the DNA amplification. All the isolates
that were found to belong to the Aeromonas genus were maintained
in LB with 30% glycerol (280uC).
Aeromonas isolates were further identified by amplifying and
sequencing the housekeeping gene rpoD, encoding s
70 factor,
which is one of the sigma factors that confer promoter-specific
transcription initiation on RNA polymerase [19]. The PCR
products were sequenced by MCLAB (San Francisco, CA). Newly
determined sequences were compared to those available in the
GenBank database, using the standard nucleotide–nucleotide
BLAST program (BLASTN; http://www.ncbi.nlm.nih.gov), to
ascertain their closest relatives. The sequences were submitted to
the GenBank database under accession numbers JF738005–
JF738021. A phylogenetic tree was generated using the neigh-
bor-joining method with NJPlot (MEGA 4.1) based on alignments
from CLUSTAL W.
Virulence Factors and Antimicrobial Susceptibility
The presence of the following genes encoding virulence factors
was determined in all Aeromonas isolates: cytotoxic enterotoxin
(act)/aerolysin (aerA)/haemolysin (hlyA) by using one set of primers
AHCF1/AHCR1 [12]; alt and ast genes for cytotonic enterotoxins;
ahyB gene for elastase; pla/lipH3/apl-1/lip genes for phospholipase;
and fla gene for flagellin [1]. The presence of the genes act/aerA/
hlyA and ast; fla and alt; ahyB and pla/lipH3/apl-1/lip was tested
simultaneously in the same reaction mixture, in accordance with
Sen and Rodgers (2004) [1]. The presence of genes encoding the
components of the type III secretion system, ascV, ascF-ascG [15],
type III secretion dependent ADP-ribosylating toxins, aexT and
aexU [20], and of lafA gene encoding a lateral flagella [13] was
determined as well.
The disk diffusion antimicrobial susceptibility tests were per-
formed by a standardized method [21,22]. All disks were pur-
chased from OXOID (UK).
Results
Aeromonas Prevalence in Diarrheal Stools
A total of 1,033 stool specimens from patients suffering from
diarrhea were monitored for the presence of Aeromonas during a five
monthperiodbetweenApril13andSeptember15,2010.Seventeen
patients (,2%) tested positive for Aeromonas species which included
11 (65%) A. caviae, five (29%) A. veronii, and one strain, (H53AQ1).
This strain showed the highest rpoD gene similarity (96%) to the
deposited sequence of the type strain of A. taiwanensis, and clustered
with this species in the phylogenetic tree (Figure 1).
The specimens of the diarrhea patients were also checked for
other enteropathogenes. The results revealed that pathogenic
bacteria, Rotavirus and parasites were recovered from about 15%
(155 of 1033) of the diarrhea patients. The prevalence of the
detected enterophathogenes was; Campylobacter sp. 5.2%, Shigella
3.3%, Salmonella enterica 2%, Aeromonas spp. 2%, Rotavirus 0.4%,
Giardia lamblia 2.3%, and Cryptosporidium parvum 0.15%. Mixed
infections were found in four patients that were positive for
Aeromonas as well as for other known enteropathogens (Table S1).
Virulence Factors and Antimicrobial Susceptibility
All Aeromonas isolates were screened for the presence of virulence
genes (Table 1). The most prevalent genes were ahyB (88%) and
pla/lipH3/apl-1/lip (71%). The two types of flagella that were
screened (polar and lateral) were quite prevalent as well (65% and
41%, respectively). In every strain that was positive for the genes
encoding the TTSS, a gene for the effector aexU was present as
well. The ast gene was found only in one isolate (H65AT3), which
was identified as A. veronii. The virulence genotypes were found in
different combinations: three isolates (18%) possessed five different
genes, four (24%) possessed three or four different genes and two
(12%) possessed two different genes (Table 1).
The susceptibility of Aeromonas isolates was evaluated against 15
antimicrobial agents. All isolates were susceptible to amikacin,
cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin and chloram-
phenicol; however, they varied in their susceptibility to other
antimicrobial agents (Table 2). The three Aeromonas species
displayed the same antibiotic sensitivity patterns.
Discussion
Despite the existence of detailed case reports and epidemiological
case control investigations, the role of Aeromonas as the etiological
agent of bacterial diarrhea has been questioned and debated several
times [3,6,11,23–27]. Figueras et al. [26] rebutted arguments
provided by several authors against considering Aeromonas a true
enteropathogenic bacterium one by one. Today it is well accepted
that if Aeromonas can cause different infections like cellulitis,
meningitis, pneumonia, wound infections and more in healthy
humans, it can also have the capacity to produce diarrhea [3,6,26].
In several reported studies throughout the world, Aeromonas
species have been isolated at a rate of 0.6 to 7.2% in patients with
diarrhea, predominantly in infants and children [2,27]. In the
current study, Aeromonas positive patients ranged in age and only
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current study relied on a limited amount of strains as it was
performed only during a period of five months; however, the
Aeromonas isolation rate amounted to about 2%, which is similar to
the rate obtained in other studies performed in other countries [3,6
and references therein], as well as in Israel in 1990 [28]. In a
recent study performed by Pablos et al. [29] in Leo ´n (Spain) they
found a frequency of Aeromonas of 4% (32 positive patients of the
800 investigated), mainly associated with infant or pediatric
patients (68.8%). Furthermore they found mixed infections with
other pathogens in 12 patients [29]. In our study, only two of the
patients were infants (12%), and all four patients that had mixed
infections were adults (Table S1).
In mixed infections, Aeromonas may be transient colonizers
lacking a causal relationship with a disease, but in some cases,
multiple pathogens may act synergistically to produce diarrhea
[30]. Aeromonas species are carried asymptomatically by some
individuals [3,6] as occurs with other recognized enteropathogens
like Salmonella. However, a study that was performed in 1990 in
Israel compared the prevalence of Aeromonas in the stools obtained
from 932 adult patients with acute diarrhea (recovered between
1986 and 1987) to 500 stools from asymptomatic controls. They
found an Aeromonas prevalence of about 2% in the diarrhea cases,
which conforms to our study. But no Aeromonas were detected in
the controls [28]. This seems to indicate a clear association of
Aeromonas with diarrhea cases in Israel, as we found in our study.
Figure 1. Phylogenetic tree of Aeromonas isolates recovered from diarrhea patients. The tree shows the relationships based on partial
sequences of rpoD gene of type strains of Aeromonas species and the isolates from the current study. The sequence alignments were performed
using the CLUSTAL W program, and the tree was generated using the neighbor–joining method with Kimura 2 parameter distances in MEGA 4.1
software. Bootstrap values (from 1,000 replicates) greater than 50% are shown at the branch points. The bar indicates 2% sequence divergence.
doi:10.1371/journal.pone.0030070.g001
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caviae and A. hydrophila are more frequently associated with
diarrhea in humans, representing 85% of clinical isolates [11].
Interestingly, none of the identified strains in the current study
belonged to A. hydrophila. This is in agreement with the false
importance attributed to this species on the basis of phenotypic
identifications [3,26]. In the current study, A. caviae was the
predominating species (65%, 11/17), followed by A. veronii that was
isolated from five patients (29%). One patient carried a strain that
was identified as A. taiwanensis (Figure 1). All the strains were










H3TK1 ++ 22 2 + 22 2 22
H15AI+1 ++ + 2 + 222 2 22
H17AD1 22 + 2 ++22 2 + 2
H22AJ4 ++ 2 2 2222 2 22
H22AG8 22 + 22 + 2 ++ 2 +
H23AM+2 ++ + 22 ++22 2 2
H30AD+5 ++ 22 2 2 + 22 2 2
H33AJ+7 + 22 2 2 + 22 2 2+
H34AA+4 ++ + 22 ++22 2 2
H35AG+1 ++ 22 2 ++22 2 2
H39AA+3 ++ 22 + 222 2 2+
H45AF+12 ++ 22 2 ++22 2 +
H45AK+3 ++ 22 2 + 22 2 22
H50AI2 ++ + 22 + 2 + 22 +
H53AQ1 + 22 2 2 + 22 + 2 +
H65AT3 2 + 2 + 22+ 22 2 2
H67AJ5 ++ 22 2 2 + 22 2 +
For more details on the isolates and on the patients see Table S1.
doi:10.1371/journal.pone.0030070.t001
Table 2. Susceptibility of Aeromonas isolates to antimicrobial agents.
Antimicrobial agent Number (%) of strains
(number of strains tested) susceptible intermediate resistance resistant
amikacin (11) 11 (100) - -
cefotaxime (11) 11 (100) - -
ceftazidime (11) 11 (100) - -
ceftriaxone (E test) (11) 11 (100) - -
ciprofloxacin (11) 11 (100) - -
chloramphenicol (11) 11 (100) - -
gentamicin (11) 10 (91) - 1 (9)
piperacillin–tazobactam (11) 10 (91) - 1 (9)
trimethoprim–sulfamethoxazole (11) 10 (91) - 1 (9)
imipenem (also meropenem) (11) 8 (73) - 3 (27)
cefoxitin (10) 7 (70) 2 (20) 1 (10)
nalidixic acid (11) 7 (64) - 4 (36)
tetracycline (11) 6 (55) - 5 (45)
amoxicillin+clavulanic acid (11) 3 (27) 3 (27) 5 (46)
cephalotin (10) 2 (20) - 8 (80)
Most of the identified strains were resistant to beta-lactam antibiotics but susceptible to third-generation cephalosporin antibiotics.
doi:10.1371/journal.pone.0030070.t002
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identification on the basis of rpoD gene sequencing is considered to
be much more accurate than 16S rRNA gene sequencing or
biochemical identification methods. The fact that many studies
found A. hydrophila a major species to cause diarrhea (among
Aeromonas species) may be due to limitations in the identification
methods that were used in those studies [3,26].
The current study provides the first clinical record of A.
taiwanensis as a diarrheal causative since this species was identified
[31]. So far, the only available strain (the type strain) was
recovered from an infected burn wound of a 40 years old male
[31] and in the current study the strain was isolated from feces of a
35 years old diarrheal female patient.
The clinical manifestations of Aeromonas associated gastroenter-
itis can range from mild self-limiting watery diarrhea to a more
severe and invasive dysenteric form. Chronic diarrhea episodes
and isolated cases of a cholera-like illness have also been described
[11]. The bacterial flagella are thought to play an important role
in pathogenicity. Aeromonas produces two types of flagella: a
constitutively expressed polar flagellum (fla) and multiple inducible
lateral flagella (laf). Both types play a role in the attachment of the
bacteria to the gastrointestinal epithelium, biofilm formation and
long-term colonization [6]. Both types of flagella (fla and lafA) were
common among the Aeromonas isolates from the patients in the
current study (Table 1). The occurrence of genes encoding
hemolytic, cytotonic, cytotoxic, and enterotoxic activities (aerA,
hlyA, alt, ast, act) may contribute to diarrheal-related virulence
[6,31,32]. In the present study, 35% of the Aeromonas isolates
possessed the act/aerA/hlyA gene. The most prevalent virulence-
associated genes in the isolates from our study were ahpB for
elastase (88%) and pla/lip/lipH3/apl-1 for lipase (71%) (Table 1).
These genes may be essential for the ability of the bacterium to
adhere and invade the intestinal mucosa [1].
Type III secretion system (TTSS) plays crucial roles in host-
pathogen interactions [14,15]. One of the best-described toxins
that are translocated via a TTSS is the ADP-ribosylating toxin,
AexT. This toxin was found to be more common among the
environmental, rather than the clinical Aeromonas strains [13]. In
our study, the gene for this toxin was detected only in one strain.
Recently, a novel type-three-secretion-dependent effector, AexU,
was discovered in Aeromonas. AexU is an ADP-ribosylating toxin
and is required for virulence of Aeromonas hydrophila in mice [20].
The gene for this toxin was quite prevalent among the strains in
our study (41%). The prevalence of the genes encoding TTSS
apparatus (12%) was lower than the aexU gene prevalence (41%).
The TTSS is probably underrepresented, as may happen in PCR
based studies. Nevertheless, the presence of aexU gene strengthens
the case of Aeromonas being recognized as a stronger pathogen.
In another study that surveyed the distribution of virulen-
ce associated genes among Aeromonas species from human stool
specimens in Spain, it was found that alt, ast, laf, aerA, and hlyA
genes were present in 72, 19, 3, 25, and 28% of the strains,
respectively. None of the strains harbored ascF – G [29]. In clinical
diarrheic isolates of A. hydrophila in Spain the distribution of
associated virulence genes was different: alt – 82%, ast – 96%, laf –
77%, aexT – 5%, ascV – 5% [13].
Aeromonas species are known to be intrinsically susceptible to all
antibiotics active against non-fastidious Gram-negative bacilli,
except for many beta–lactams, due to the production of multiple
inducible, chromosomally encoded b–lactamases [33]. In our
study, most strains (80%) were resistant to cephalotin and partially
resistant to amoxicillin combined with clavulanic acid (46%)
(Table 2). All strains were susceptible to third-generation
cephalosporin antibiotics (cefotaxime, ceftazidime, ceftriaxone),
second-generation fluoroquinolone antibiotics – ciprofloxacin,
aminoglycoside antibiotic – amikacin, and to chloramphenicol.
Recently, it was found that the egg masses of chironomids, non-
biting midges, (Diptera; Chironomidae) serve as a natural reservoir for
Aeromonas pathogenic species [34,35] as well as for Vibrio cholerae
[36]. Chironomid infestations in drinking water supply systems
are an existing problem in Israel [37] and worldwide [38].
Chironomids may disseminate pathogenic species of Aeromonas
between drinking water reservoirs, as was suggested for V. cholerae
[39].
The source of Aeromonas in diarrheal patients was not in-
vestigated in the current study. In order to investigate the route of
transmission of Aeromonas pathogenic strains an extensive study on
strains from various origins should be performed. Chironomid egg
masses in drinking water ponds and tap waters should be screened
for Aeromonas isolates and compared with isolates from diarrheal
patients.
Aeromonas infections are self–limiting, but their diagnosis may be
crucial in young children, old and immunocompromised patients.
We conclude that Aeromonas may be a causative agent of diarrhea
in patients in Israel and therefore should be included in routine
bacteriological screenings.
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